Skip to main content

What the FDA labels say about taking them together

Ivacaftor and rifampin

Ivacaftor's FDA label of March 23, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name ivacaftor. The ivacaftor label: “Concomitant use with strong CYP3A inducers substantially decreases exposure of ivacaftor, which may diminish effectiveness.”

Check it at the source: the ivacaftor FDA label on DailyMed (effective March 23, 2026, Vertex Pharmaceuticals Incorporated); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the ivacaftor label say about rifampin?

Ivacaftor label, drug interactions

Inducers of CYP3A Co-administration with rifampin, a strong CYP3A inducer, significantly decreased ivacaftor exposure (AUC) by approximately 9-fold.

Ivacaftor label, warnings and precautions

Concomitant use with strong CYP3A inducers (e.g., rifampin, St. John's wort) substantially decreases exposure of ivacaftor, which may diminish effectiveness.

Source: FDA drug label (Kalydeco), Vertex Pharmaceuticals Incorporated, effective March 23, 2026 (SPL set 0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25), via openFDA; the full label on DailyMed

What does the rifampin label say about ivacaftor?

Rifampin's label (effective February 11, 2026) does not name ivacaftor in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Ivacaftor generic labelers
13Rifampin generic labelers
IvacaftorRifampin
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?